The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Mechanisms of chemoresistance in cancer stem cells
Open accessAbstract
Chemotherapy is one of the standard methods of treatment in many cancers. While chemotherapy is often capable of inducing cell death in tumors and reducing the tumor bulk, many cancer patients experience recurrence and ultimately death because of treatment failure. In recent years, cancer stem cells (CSCs) have gained intense interest as key tumor‐initiating cells that may also play an integral role in recurrence following chemotherapy. As such, a number of mechanisms of chemoresistance have been identified in CSCs. In this review, we describe a number of these mechanisms of chemoresistance including ABC transporter expression, aldehyde dehydrogenase (ALDH) activity, B‐cell lymphoma‐2 (BCL2) related chemoresistance, enhanced DNA damage response and activation of key signaling pathways. Furthermore, we evaluate studies that demonstrate potential methods for overcoming chemoresistance and treating chemoresistant cancers that are driven by CSCs. By understanding how tumor‐initiating cells such as CSCs escape chemotherapy, more informed approaches to treating cancer will develop and may improve clinical outcomes for cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,820
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280 · cited 1×
“ABCG2 is found in milk ducts of the mammary gland, hematopoietic stem cells and the blood brain barrier [27-29].”
BackgroundPhenotypic characterization of human colorectal cancer stem cells
Dalerba, P., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,184
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Identification and expansion of the tumorigenic lung cancer stem cell population
Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., Conticello, C., Ruco, L., Peschle, C., & De Maria, R. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402283 · Cited by 1,707
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
Veis, D. J., Sorenson, C. M., Shutter, J. R., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80065-m · Cited by 1,628
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, S., Balch, C., Chan, M. W., Lai, H.-C., Matei, D., Schilder, J. M., Yan, P. S., Huang, T. H.-M., & Nephew, K. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0364 · Cited by 1,293
The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer
(2010) · Advances in Cancer Research · doi:10.1016/b978-0-12-380888-2.00003-0 · Cited by 1,276
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Massive Cell Death of Immature Hematopoietic Cells and Neurons in Bcl-x-Deficient Mice
Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K.-I., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995) · Science · doi:10.1126/science.7878471 · Cited by 1,163
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,039
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line
Kondo, T., Setoguchi, T., & Taga, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307618100 · Cited by 985
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
Strasser, A., Harris, A. W., Bath, M. L., & Cory, S. (1990) · Nature · doi:10.1038/348331a0 · Cited by 905
The diverse and complex roles of NF-κB subunits in cancer
Perkins, N. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3204 · Cited by 852
Retinoic acid signalling during development
Rhinn, M., & Dollé, P. (2012) · Development · doi:10.1242/dev.065938 · Cited by 849
Notch signalling in solid tumours: a little bit of everything but not all the time
Ranganathan, P., Weaver, K. L., & Capobianco, A. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3035 · Cited by 824
Ma, S., Lee, T. K., Zheng, B.-J., Chan, K. W., & Guan, X.-Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210811 · Cited by 775
A Southwest Oncology Group study
Jenkins, T. R., Tangen, C. M., Macdonald, J. S., Weiss, G. R., Chapman, R. M., & Hantel, A. (1993) · Cited by 773
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Szotek, P. P., Pieretti-Vanmarcke, R., Masiakos, P. T., Dinulescu, D. M., Connolly, D., Foster, R., Dombkowski, D., Preffer, F., MacLaughlin, D. T., & Donahoe, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603672103 · Cited by 751
Chiba, T., Kita, K., Zheng, Y.-W., Yokosuka, O., Saisho, H., Iwama, A., Nakauchi, H., & Taniguchi, H. (2006) · Hepatology · doi:10.1002/hep.21227 · Cited by 664
Quintana, E., Shackleton, M., Foster, H. R., Fullen, D. R., Sabel, M. S., Johnson, T. M., & Morrison, S. J. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.012 · Cited by 599
Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo
Zhao, C., Blum, J., Chen, A., Kwon, H. Y., Jung, S. H., Cook, J. M., Lagoo, A., & Reya, T. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.003 · Cited by 592
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith-Berdan, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002428 · Cited by 589
Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
Chow, E. K., Zhang, X.-Q., Chen, M., Lam, R., Robinson, E., Huang, H., Schaffer, D., Osawa, E., Goga, A., & Ho, D. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001713 · Cited by 556
Self-citationStorms, R. W., Trujillo, A. P., Springer, J. B., Shah, L., Colvin, O. M., Ludeman, S. M., & Smith, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9118 · Cited by 551
Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D. D., Miyake, K., Resau, J. H., & Bates, S. E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.2011 · Cited by 538
Alvero, A. B., Chen, R., Fu, H.-H., Montagna, M., Schwartz, P. E., Rutherford, T., Silasi, D.-A., Steffensen, K. D., Waldstrom, M., Visintin, I., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7533 · Cited by 489
Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
Ma, S., Chan, K. W., Lee, T. K.-W., Tang, K. H., Wo, J. Y.-H., Zheng, B.-J., & Guan, X.-Y. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0035 · Cited by 459
Goldenberg, M. M. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88288-0 · Cited by 453
The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
Kelly, P. N., & Strasser, A. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.17 · Cited by 453
Clay, M. R., Tabor, M., Owen, J. H., Carey, T. E., Bradford, C. R., Wolf, G. T., Wicha, M. S., & Prince, M. E. (2010) · Head & Neck · doi:10.1002/hed.21315 · Cited by 447
Jonker, J. W., Merino, G., Musters, S., van Herwaarden, A. E., Bolscher, E., Wagenaar, E., Mesman, E., Dale, T. C., & Schinkel, A. H. (2005) · Nature Medicine · doi:10.1038/nm1186 · Cited by 423
Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V, Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.126 · Cited by 421
Localisation of breast cancer resistance protein in microvessel endothelium of human brain
Cooray, H. C., Blackmore, C. G., Maskell, L., & Barrand, M. A. (2002) · NeuroReport · doi:10.1097/00001756-200211150-00014 · Cited by 419
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
Baba, T., Convery, P. A., Matsumura, N., Whitaker, R. S., Kondoh, E., Perry, T., Huang, Z., Bentley, R. C., Mori, S., Fujii, S., et al. (2009) · Oncogene · doi:10.1038/onc.2008.374 · Cited by 419
Sullivan, J. P., Spinola, M., Dodge, M., Raso, M. G., Behrens, C., Gao, B., Schuster, K., Shao, C., Larsen, J. E., Sullivan, L. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0881 · Cited by 416
Mcl-1 deficiency results in peri-implantation embryonic lethality
Rinkenberger, J. L., Horning, S., Klocke, B., Roth, K., & Korsmeyer, S. J. (2000) · Genes & Development · doi:10.1101/gad.14.1.23 · Cited by 397
Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells
Yang, W., Yan, H.-X., Chen, L., Liu, Q., He, Y.-Q., Yu, L.-X., Zhang, S.-H., Huang, D.-D., Tang, L., Kong, X.-N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6691 · Cited by 378
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Steg, A. D., Bevis, K. S., Katre, A. A., Ziebarth, A., Dobbin, Z. C., Alvarez, R. D., Zhang, K., Conner, M., & Landen, C. N. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2188 · Cited by 359
Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant
Print, C. G., Loveland, K. L., Gibson, L., Meehan, T., Stylianou, A., Wreford, N., de Kretser, D., Metcalf, D., Köntgen, F., Adams, J. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12424 · Cited by 335
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
McAuliffe, S. M., Morgan, S. L., Wyant, G. A., Tran, L. T., Muto, K. W., Chen, Y. S., Chin, K. T., Partridge, J. C., Poole, B. B., Cheng, K.-H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206400109 · Cited by 328
Role of mitochondria as the gardens of cell death
Kim, R., Emi, M., & Tanabe, K. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0111-7 · Cited by 326
Hypoxia Links ATR and p53 through Replication Arrest
Hammond, E. M., Denko, N. C., Dorie, M. J., Abraham, R. T., & Giaccia, A. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1834-1843.2002 · Cited by 324
Bisson, I., & Prowse, D. M. (2009) · Cell Research · doi:10.1038/cr.2009.43 · Cited by 308
Meng, R. D., Shelton, C. C., Li, Y.-M., Qin, L.-X., Notterman, D., Paty, P. B., & Schwartz, G. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2088 · Cited by 287
Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.
Graninger, W. B., Seto, M., Boutain, B., Goldman, P., & Korsmeyer, S. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113235 · Cited by 281
Corti, S., Locatelli, F., Papadimitriou, D., Donadoni, C., Salani, S., Del Bo, R., Strazzer, S., Bresolin, N., & Comi, G. P. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0217 · Cited by 280
Jimeno, A., Feldmann, G., Suárez-Gauthier, A., Rasheed, Z., Solomon, A., Zou, G.-M., Rubio-Viqueira, B., García-García, E., López-Ríos, F., Matsui, W., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0924 · Cited by 276
Human aldehyde dehydrogenases: Potential pathological, pharmacological, and toxicological impact
Sládek, N. E. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10057 · Cited by 266
Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells
Kawabata, S., Oka, M., Shiozawa, K., Tsukamoto, K., Nakatomi, K., Soda, H., Fukuda, M., Ikegami, Y., Sugahara, K., Yamada, Y., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4267 · Cited by 242
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia.
Pegoraro, L., Palumbo, A., Erikson, J., Falda, M., Giovanazzo, B., Emanuel, B. S., Rovera, G., Nowell, P. C., & Croce, C. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7166 · Cited by 231
Clinical Implications of the Cancer Genome
MacConaill, L. E., & Garraway, L. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4944 · Cited by 229
Cheung, A. M. S., Wan, T. S. K., Leung, J. C. K., Chan, L. Y. Y., Huang, H., Kwong, Y. L., Liang, R., & Leung, A. Y. H. (2007) · Leukemia · doi:10.1038/sj.leu.2404721 · Cited by 226
Chau, W. K., Ip, C. K., Mak, A. S. C., Lai, H.-C., & Wong, A. S. T. (2013) · Oncogene · doi:10.1038/onc.2012.290 · Cited by 220
Ulasov, I. V., Nandi, S., Dey, M., Sonabend, A. M., & Lesniak, M. S. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00062 · Cited by 204
Accelerated Neutrophil Apoptosis in Mice Lacking A1-a, a Subtype of the bcl-2–related A1 Gene
Hamasaki, A., Sendo, F., Nakayama, K., Ishida, N., Negishi, I., Nakayama, K.-I., & Hatakeyama, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.1985 · Cited by 199
Flahaut, M., Meier, R., Coulon, A., Nardou, K. A., Niggli, F. K., Martinet, D., Beckmann, J. S., Joseph, J.-M., Mühlethaler-Mottet, A., & Gross, N. (2009) · Oncogene · doi:10.1038/onc.2009.80 · Cited by 190
Cancer Stem Cells in Solid Tumors: An Overview
O'Brien, C. A., Kreso, A., & Dick, J. E. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.11.001 · Cited by 177
Dalton, W. S., Crowley, J. J., Salmon, S., Grogan, T. M., Laufman, L. R., Weiss, G. R., & Bonnet, J. D. (1995) · Cancer · doi:10.1002/1097-0142(19950201)75:3<815::aid-cncr2820750311>3.0.co;2-r · Cited by 175
Aldehyde dehydrogenase activity as a functional marker for lung cancer
Ucar, D., Cogle, C. R., Zucali, J. R., Ostmark, B., Scott, E. W., Zori, R., Gray, B. A., & Moreb, J. S. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.09.029 · Cited by 171
Konopleva, M., Zhao, S., Hu, W., Jiang, S., Snell, V., Weidner, D., Jackson, C. E., Zhang, X., Champlin, R., Estey, E., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03637.x · Cited by 171
Song, Z., Yue, W., Wei, B., Wang, N., Li, T., Guan, L., Shi, S., Zeng, Q., Pei, X., & Chen, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017687 · Cited by 170
Cammareri, P., Scopelliti, A., Todaro, M., Eterno, V., Francescangeli, F., Moyer, M. P., Agrusa, A., Dieli, F., Zeuner, A., & Stassi, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3953 · Cited by 159
Hedgehog pathway as a drug target: Smoothened inhibitors in development
Lin, T. L., & Matsui, W. H. (2012) · OncoTargets and Therapy · doi:10.2147/ott.s21957 · Cited by 145
P‐Glycoprotein‐Mediated Hoechst 33342 Transport Out of the Lipid Bilayer
Shapiro, A. B., Corder, A. B., & Ling, V. W. T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00115.x · Cited by 144
Noda, T., Nagano, H., Takemasa, I., Yoshioka, S., Murakami, M., Wada, H., Kobayashi, S., Marubashi, S., Takeda, Y., Dono, K., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605064 · Cited by 129
Ikawa, M., Impraim, C. C., Wang, G., & Yoshida, A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32405-0 · Cited by 119
Targeting Hypoxic Cells through the DNA Damage Response
Olcina, M. M., Lecane, P. S., & Hammond, E. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0286 · Cited by 119
Cancer stem cells in human gastrointestinal cancers
Haraguchi, N., Inoue, H., Tanaka, F., Mimori, K., Utsunomiya, T., Sasaki, A., & Mori, M. (2006) · Human Cell · doi:10.1111/j.1749-0774.2005.00004.x · Cited by 119
Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway
Singh, S. P., Chitkara, D., Mehrazin, R., Behrman, S. W., Wake, R. W., & Mahato, R. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040021 · Cited by 115
Gallmeier, E., Hermann, P. C., Mueller, M.-T., Machado, J. G., Ziesch, A., Toni, E. N. D., Palagyi, A., Eisen, C., Ellwart, J. W., Rivera, J., et al. (2011) · Stem Cells · doi:10.1002/stem.595 · Cited by 106
Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells
Chow, E. K., Fan, L., Chen, X., & Bishop, M. J. (2012) · Hepatology · doi:10.1002/hep.25776 · Cited by 103
Self-citationCD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours.
Madjd, Z., Mehrjerdi, A. Z., Sharifi, A. M., Molanaei, S., Shahzadi, S. Z., & Asadi‐Lari, M. (2009) · PubMed · Cited by 97
Sensitization of Pancreatic Cancer Stem Cells to Gemcitabine by Chk1 Inhibition
Venkatesha, V. A., Parsels, L. A., Parsels, J. D., Zhao, L., Zabludoff, S., Simeone, D. M., Maybaum, J., Lawrence, T. S., & Morgan, M. A. (2012) · Neoplasia · doi:10.1593/neo.12538 · Cited by 91
Duong, H., Hwang, J. S., Kim, H. J., Kang, H. J., Seong, Y., & Bae, I. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1516 · Cited by 91
Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells
Hellsten, R., Johansson, M., Dahlman, A., Sterner, O., & Bjartell, A. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022118 · Cited by 91
Christgen, M., Ballmaier, M., Bruchhardt, H., von Wasielewski, R., Kreipe, H. H., & Lehmann, U. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9570-y · Cited by 84
Cyclophosphamide resistance in medulloblastoma.
Friedman, H. S., Colvin, O. M., Kaufmann, S. H., LUDEMAN, S. M., Bullock, N., Dd, B., & Griffith, O. W. (1992) · PubMed · Cited by 80
Regulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells
Leizer, A. L., Alvero, A. B., Fu, H. H., Holmberg, J. C., Cheng, Y., Silasi, D., Rutherford, T., & Mor, G. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00914.x · Cited by 67
Lancet, J. E., Baer, M. R., Durán, G. E., List, A. F., Fielding, R. M., Marcelletti, J. F., Multani, P. S., & Sikic, B. I. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.015 · Cited by 54
Moreb, J. S., Maccow, C., Schweder, M., & Hecomovich, J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39247-x · Cited by 53
Sreerama, L., & Sládek, N. E. (1997) · PubMed · Cited by 52
Hsu, L. C., Chang, W.-C., Hoffmann, I., & Duester, G. (1999) · Biochemical Journal · doi:10.1042/bj3390387 · Cited by 50
Yao, J. J., An, Y., Wie, J., Chen, P., Miao, Y., Ji, Z., Lu, Z. P., Jl, W., Jiang, K., & Xu, Z. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13208 · Cited by 46
(2003) · PubMed
Cited by
EMT, cell plasticity and metastasis
Chaffer, C. L., San Juan, B. P., Lim, E., & Weinberg, R. A. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9648-7 · Cited by 861
Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26845 · Cited by 721
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Cancer Nanomedicine: From Drug Delivery to Imaging
Chow, E. K.-H., & Ho, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005872 · Cited by 491
Self-citationEMT: Mechanisms and therapeutic implications
Singh, M., Yelle, N., Venugopal, C., & Singh, S. K. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.009 · Cited by 475
Metadata
- Authors
- Abdullah, L. N., & Chow, E. K.
- Venue
- Clinical and Translational Medicine
- Publisher
- Wiley
- Published
- 2013-01-17
- Volume
- 2
- Issue
- 1
- Pages
- 3-3
- ISSN
- 2001-1326 (ISSN-L)
- OpenAlex
- W2124185479
- Cited by
- 721
- References
- 93
- FWCI
- 29.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.